Pfizer:

For our latest Event Impact Assessment, our team of skilled analysts reviewed Pfizer 1Q22 results on 3 May 2022. Based on their analysis, they have issued a buy recommendation for this share. Click here to find out more.

Johnson & Johnson:

Our team of skilled analysts recently reviewed their recommendation for Johnson & Johnson. Listen to this recording to find out which factors they considered to reach their hold recommendation.

PSG's advice focused business is founded on personal service, lifelong relationships with clients, integrity, trust and transparency. These values are encapsulated in the group's core business principles. The opinions expressed in these podcasts are the opinions of the series and not necessarily those of PSG. The information in these podc ...